Isotopic labeling affects 1,25-dihydroxyvitamin D metabolism.

Isotope substitution can change the biochemical properties of vitamin D. To determine the effect of substituting 3H for 1H on the metabolism of 1,25(OH)2D3, we measured the metabolic clearance rate and renal metabolism of unlabeled and 3H-labeled 1,25(OH)2D3. Substitution of 3H for 1H on carbons 26 and 27 [1,25(OH)2[26,27(n)-3H]D3] or on carbons 23 and 24 [1,25(OH)2[23,24(n)-3H]D3] reduced the in vivo metabolic clearance rate of 1,25(OH)2D3 by 36% and 37%, respectively, and reduced the in vitro renal catabolism of 1,25(OH)2D3 by 11% and 54%, respectively. Substitutions of 3H for 1H on carbons 23 and 24 as opposed to carbons 26 and 27 reduced conversion of [3H]1,25(OH)2D3 to [3H]1,24,25(OH)2D3 by 25% and to putative 24-oxo-1,23,25-dihydroxyvitamin D3 by 1600%. These results indicate that substitution of 3H for 1H on carbons 26 and 27 or on carbons 23 and 24 can reduce the metabolic clearance rate and in vitro metabolism of 1,25(OH)2D3 and quantitatively alter the pattern of metabolic products produced.

[1]  R. Rizza,et al.  Assessment of insulin action in insulin-dependent diabetes mellitus using [6(14)C]glucose, [3(3)H]glucose, and [2(3)H]glucose. Differences in the apparent pattern of insulin resistance depending on the isotope used. , 1986, The Journal of clinical investigation.

[2]  R. Globus,et al.  Chronic 1,25-dihydroxyvitamin D3 administration in the rat reduces the serum concentration of 25-hydroxyvitamin D by increasing metabolic clearance rate. , 1986, The Journal of clinical investigation.

[3]  A. Langenhove.  Isotope Effects: Definitions and Consequences for Pharmacologic Studies , 1986 .

[4]  S. Kornfeld.  Trafficking of lysosomal enzymes in normal and disease states. , 1986, The Journal of clinical investigation.

[5]  R. Morris,et al.  Oral intake of phosphorus can determine the serum concentration of 1,25-dihydroxyvitamin D by determining its production rate in humans. , 1986, The Journal of clinical investigation.

[6]  J. L. Napoli,et al.  Production of C-24- and C-23-oxidized metabolites of 1,25-dihydroxycholecalciferol by cultured kidney cells (LLC PK1) and their presence in kidney in vivo. , 1984, The Biochemical journal.

[7]  D. Bikle,et al.  Separation of isotopically laboled vitamin D metabolises by high-performance liquid chromatography , 1984 .

[8]  G. Jones,et al.  The isolation and identification of two new metabolites of 25-hydroxyvitamin D3 produced in the kidney. , 1983, The Journal of biological chemistry.

[9]  H. DeLuca,et al.  Primary isotope effect of tritium on the hydroxylations of 25-hydroxyvitamin D3. , 1982, Archives of biochemistry and biophysics.

[10]  W. Carter.  Mechanisms of cross-species activity of mammalian interferons. , 1979, Pharmacology & therapeutics.

[11]  J. Oates,et al.  The role of prostaglandins in the pathogenesis of human disease: elucidation with stable isotopic methods , 1978 .

[12]  H. V. Hal,et al.  Unexpected high-performance liquid chromatographic separation of Org GC 94 and [3,3,4,4-2H4]Org GC 94 , 1976 .

[13]  J. Katz,et al.  Studies with deuterated drugs. , 1975, Journal of pharmaceutical sciences.

[14]  H. DeLuca,et al.  Biological activity of 25-hydroxyergocalciferol in rats. , 1970, The Journal of nutrition.

[15]  C. Mitoma,et al.  The pharmacologic effect of deuterium substitution on 5-n-butyl-5-ethylbarbituric acid. , 1969, Life sciences.

[16]  H. Rapoport,et al.  Effect of Deuteration of N—CH3 Group on Potency and Enzymatic N-Demethylation of Morphine , 1961, Science.

[17]  J. Bigeleisen.  The Validity of the Use of Tracers to Follow Chemical Reactions. , 1949, Science.